Moreover, HMGA2 interacts with poly(ADP-ribose) polymerase 1 (PARP1) by enhancing PARP1 activity and reducing cancer cell sensitivity to olaparib (a PARP inhibitor) (11). The gene discussed is PARP1; the disease is cancer.